Skip to main content
. 2021 Jun 21;13(12):3101. doi: 10.3390/cancers13123101

Figure 1.

Figure 1

Flowchart showing total number of patients recruited for study and reasons for exclusion from further evaluation and ctDNA analysis. The type of mutations in tissue positive cohort are at baseline (pretreatment). Tissue positive cohort included patients with at least one melanoma-associated mutation in tissue specimen. Tissue negative cohort consisted of patients without a mutation in tissue specimen. ctDNA: circulating tumor DNA.